Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Intensive Chemotherapy for Cancer in Children with Ataxia-Telangiectasia
NCT00187057Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Sep 2002
- Primary completion
- Aug 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of vinblastine, vincristine, prednisone, daunorubicin, asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), B-cell non-Hodgkin lymphoma, Hodgkin lymphoma (HL), sponsored by St. Jude Children's Research Hospital. Started Sep 2002; status: completed.
02
Drugs
vinblastinevincristineprednisonedaunorubicinasparaginase escherichia coli
03
Conditions
acute lymphoblastic leukemia (ALL)B-cell non-Hodgkin lymphomaHodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00187057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187057.